Short answer
Sabra Health Care REIT, Inc. (SBRA) filed its Q2 2026 10-Q quarterly report on Aug 3, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $129M (up 63.1% year over year) with net income of −$25M.
Q2 2026 key financials · XBRL
- Revenue
- $129M
- +63.1% YoY · +10.4% QoQ
- Net income
- −$25M
- −138.5% YoY · −161.6% QoQ
- EPS (diluted)
- −$0.10
- −137.0% YoY · −162.5% QoQ
Source: XBRL data from the Sabra Health Care REIT, Inc. (SBRA) Q2 2026 10-Q on SEC EDGAR. USD.
Sabra Health Care REIT, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $235.9M, up $46.7M or 25% YoY, driven by resident fees and services
- Resident fees and services strongest line at $128.8M, up $49.8M or 63% YoY
- Loan-loss provision $102.4M versus $0.2M recovery YoY, primarily tied to Recovery Centers of America repayment
- Acquisitions totaled $287.6M during six months; dispositions generated $37.7M quarterly net real-estate gains
- Headwinds: inflation, higher operating expenses, capital-market volatility, tenant and borrower default risks
Risk Factors
- No risk-factor section provided; only insider-trading disclosure and exhibits
- Executive share-sale risk: Rule 10b5-1 Plan covers potential sale of 200,000 shares
- Market signaling risk: CEO’s planned sales commence September 8, 2026
- Governance disclosure: Plan terminates March 10, 2027 or when all shares sell
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Sabra Health Care REIT, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.